Lydian Announces Non-Invasive Orthopedic Stem Cell Treatments In Guro, Seoul
Seoul, Korea, Republic of, July 13, 2025 -- The Lydian Cosmetic Surgery Clinic in Gangnam, Seoul, has announced its autologous stem cell treatments for orthopedic applications—all supervised by Dr. Abraham An, the clinic's head physician.
For more information, visit https://www.lydianclinic.com/
These treatments address chronic conditions such as joint pain and age-related degeneration of the joints, tendons, ligaments, and other tissues. Lydian has conducted stem cell research since 2005 and holds Ministry of Health and Welfare approval as an advanced regenerative medicine institution. This official recognition places the clinic among select facilities authorized to perform advanced regenerative procedures in South Korea.
The clinic's autologous approach uses cells from the patient's own body, reducing rejection possibilities. Lydian extracts stem cells through three methods—from blood, bone marrow, and fat tissues—allowing for personalized treatment protocols based on specific patient requirements. This multi-source extraction capability represents a significant advancement over single-source methods.
Safety remains paramount at the facility, which maintains a Class sterile room with 10,000-level cleanliness standards to prevent contamination during cell processing. This controlled environment preserves cell quality before reinjection. The clinic's commitment to sterile processing helps ensure the integrity of the extracted stem cells throughout the treatment process.
The non-surgical injection method differs from surgical stem cell treatments that require incisions and carry higher complication risks. Lydian's process involves extracting cells, processing them under controlled conditions, and administering them through targeted injections. This approach typically results in shorter recovery times compared to surgical alternatives, a critical factor for those with limited mobility due to orthopedic problems.
The clinic's research background spans nearly two decades, during which they have refined their stem cell extraction and processing techniques. This long-term research focus has enabled the development of specialized protocols for various internal medicine applications, particularly for chronic conditions that may benefit from regenerative approaches.
Located at 836 Nonhyeon-ro in Sinsa-dong, Gangnam, the clinic welcomes patients from the Guro district interested in these specialized treatments.
To learn more about Lydian Cosmetic Surgery Clinic's orthopedic stem cell treatments, visit https://www.lydianclinic.com/
Contact Info:
Name: Dr. Abraham An
Email: Send Email
Organization: Lydian Cosmetic Surgery Clinic
Address: 836 Nonhyeon-ro, Sinsa-dong, Gangnam, Seoul, Seoul 06025, Korea, Republic of
Phone: +82-10-9692-5508
Website: https://www.lydianclinic.com/
Release ID: 89164570
In the event of detecting errors, concerns, or irregularities in the content shared in this press release that require attention or if there is a need for a press release takedown, we kindly request that you inform us promptly by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will promptly address your feedback within 8 hours and take necessary actions to resolve any identified issues diligently or guide you through the removal process. Providing accurate and dependable information is our utmost priority.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 hours ago
- Yahoo
AESTURA, Korea's #1 Dermatologist-Recommended Dermocosmetic Brand Launches Exclusively at Sephora Australia
Premium dermocosmetic brand specialising in sensitive skin launches from August 26th, bringing clinically-proven innovation to Australian skincare market SYDNEY, July 28, 2025 /PRNewswire/ -- AESTURA, Korea's #1 dermatologist-recommended dermocosmetic brand for sensitive skin[1], breaks new ground in the Australian skincare market with its exclusive launch at Sephora Australia stores and on beginning August 26th, 2025. This strategic partnership with Sephora Australia answers the growing demand for advanced, science-backed solutions in the dermatologist skincare category. AESTURA is more than just a skincare brand. It is the culmination of over 40 years of scientific research and dermatological expertise. AESTURA's specialised sensitive skin solutions are trusted by dermatologists at Korea's leading medical institutions. The brand has been ranked as the No. 1 cosmetic brand sold in skin clinics for 9 consecutive years[2], and has widespread distribution, reaching 100% of tertiary general hospitals in South Korea[3]. "We are thrilled to introduce AESTURA to our Australian beauty community," says Sheila Dam, Brand General Manager at AESTURA. "Our products and formulas have been trusted by Korean dermatologists and sensitive-skin users alike for decades, and now, with this launch at Sephora Australia, we are excited to share these innovative sensitive-skin solutions to a wider audience." AESTURA's innovative skincare harnesses patented Triple-Lipid Technology™, featuring one million ceramide capsules in every bottle engineered to mimic the skin's natural structure and target the fundamental pillars of skin health: hydration, protection, and restoration. The ATOBARRIER365 Collection: Hero Products for Sensitive Skin At the heart of AESTURA's breakthrough skincare is the ATOBARRIER365 Collection, featuring the viral sensation ATOBARRIER365 Cream. The hero product has become a phenomenon in Korea, with one cream sold every 7 seconds[6] due to its proven ability to strengthen, protect and hydrate the skin. The ATOBARRIER365 Cream features patented technology with one million capsules packed with ceramides in every bottle[4]. These capsules stay on the skin for up to 18 hours[5], delivering hydration while strengthening, repairing, and protecting the moisture barrier which can be weakened in sensitive skin. "Sensitive skin often struggles with compromised skin barrier, making it more susceptible to dryness and irritation," says Dr. Richard D. Granstein, an academic dermatologist and Chair of AESTURA's Derma-Science Advisory Board. Additionally, according to Dr. Y. Claire Chang, board-certified dermatologist at UnionDerm and clinical instructor at Mount Sinai Hospital, "For those with sensitive skin, ceramides are crucial. It's not just about any ceramides, though. Sensitive skin benefits most from specific ceramides that mimic those naturally found in the skin. AESTURA's innovative capsule technology, used in the ATOBARRIER365 Cream, encapsulates these barrier-boosting ceramides, allowing for deeper penetration to help rebuild and strengthen the skin's natural barrier. Results reported from a clinical trial of the ATOBARRIER365 Cream demonstrated significantly enhanced skin hydration and improved barrier function." The complete ATOBARRIER365 Collection includes products formulated to address specific skin concerns like dryness, irritation, and barrier damage while enhancing overall skin health. Each product is designed for daily use, providing a complete routine specifically developed for sensitive skin needs. Exclusive Launch at Sephora Australia The exclusive partnership with Sephora Australia underscores both brands' commitment to offering premium, results-driven skincare solutions. Sephora's reputation for curating the world's most coveted beauty brands makes it the ideal retail partner for AESTURA's Australian debut. "Sephora Australia is excited to exclusively launch AESTURA, bringing our clients access to Korea's most trusted dermocosmetic brand," says Mark O'Keefe, Country Manager Sephora ANZ. "Our clients value effective, results-driven skincare, and AESTURA delivers on this by offering cutting-edge solutions specifically designed for sensitive skin that support barrier health. We look forward to introducing AESTURA to our Sephora community and know that it will be a valuable addition to our assortment." Market Impact and Availability The Australian launch comes at a time when consumer interest in K-beauty and dermocosmetic products continues to grow, with Australian consumers increasingly seeking scientifically-backed skincare solutions and prioritising genuine skin health over trend-driven routines. Australia's harsh environmental factors - from intense UV exposure to dramatic seasonal transitions - demand skincare solutions of exceptional calibre. AESTURA's arrival fills a crucial gap in the market for dermatologist-recommended brand that combine Korean innovation with clinical credibility. Starting August 26th, AESTURA products will be available at all Sephora Australia and New Zealand stores nationwide and through Sephora's online platform, ensuring accessibility for customers across the country. [1]Based on research conducted by Kantar with dermatologists in South Korea, 2023. [2]Korea Consumer Agency, 2016-2024, Best Brand Award of the Year in the category of cosmetic brands sold in skin clinics. [3]Distribution Partners Based on Health Insurance Review & Assessment Service (HIRA) Statistical Figures [4]80mL/2.7 fl. oz. [5]Ex-vivo test on human skin [6]3M Units Sales: 2018.09 ~ 2024.01 cumulative unit sales1 sold every 7 seconds : 2024.01 unit sales About AESTURA AESTURA is Korea's #1 dermatologist-recommended dermocosmetic brand, dedicated to developing scientifically-proven skincare solutions that bridge the gap between cosmetics and dermatological care. Founded on the principle of combining advanced research with gentle effectiveness, AESTURA has earned the trust of Korean dermatologists and consumers alike. The brand's commitment to clinical excellence and innovation has made it a leader in the Korean beauty industry and a sought-after name in global skincare markets. For more information about AESTURA, visit View original content to download multimedia: SOURCE AESTURA Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Medscape
3 days ago
- Medscape
Cloud Coffee: A Viral Drink That May Be a Healthy Choice
Another day, another viral TikTok drink. The beverage making the rounds right now is cloud coffee. The name alone sounds light and refreshing, which is exactly what many of us look for in a summer coffee drink. But what is actually in it, and is it any good for us? Cloud coffee is a chilled espresso drink made by layering Dalgona coffee over coconut water to yield a cold coffee beverage that is as beautiful as it is refreshing. Dalgona coffee, which originated in Macau in Southern China, consists of coffee powder, hot water, and sugar well beaten and layered over milk. It can be served hot or cold and it was named after the Korean candy that shares its caramel color. This whipped 'cloud' mixture is poured over a base of ice and coconut water, inspired by the coconut water americano that was also popular this spring. A coconut water americano is a simple drink that combines coconut water and espresso for a refreshing cold coffee beverage. Health Benefits From iced coffee to mocha protein shakes, the summertime coffee drinker in us is always happy with a chilled treat with a bit of caffeine. The question is, how healthy is this coffee swap for our chronic coffee drinkers? As with most things, it can be a good choice in moderation. A 16-ounce serving with 2 teaspoons of sugar contains about 150 calories, 5 g of protein, and even with a double shot of espresso, only about 120 mg of caffeine. That's comparable to the caffeine in a 12-ounce drip coffee. The addition of coconut water makes it a good source of potassium, a nutrient that is underconsumed by most Americans. Coffee is known around the world for its effect on cognition and energy levels, but it is also high in antioxidants. Caffeine and chlorogenic acid can promote a decrease in oxidative stress and improve inflammation. A pretty great way to start a hot summer day! While some recipes call for cream, I recommend whole fat milk to ensure adequate creaminess while incorporating more protein. Protein and fat both promote satiety, and a high protein diet can promote weight loss. Protein also has the added benefit of slowing down digestion and thus absorption of caffeine to allow for a slower uptake of caffeine over a longer time. This may help maintain energy levels and reduce any unpleasant side effects of caffeine such as elevated blood pressure. While I don't often recommend artificial sweeteners, the sugar in this drink could be swapped for aspartame or stevia without affecting the integrity of the whipped Dalgona coffee for those who prefer a sugar-free option. Maybe Not for Everyone While such a beverage is likely to be a refreshing treat for most, it may not be appropriate for all. Caffeine-containing beverages may not be the right choice for those prone to gastrointestinal issues like irritable bowel syndrome with diarrhea due to the stimulating effects of caffeine on the bowel or on those with high blood pressure due to its properties as a vasoconstrictor. Caffeine is a well-known diuretic, so I typically recommend limiting caffeine-containing beverages to no more than 2 or 3 a day, especially during the warm summer months when we may be more at risk of dehydration. Healthy and Refreshing Alternatives As cloud coffee may not be the right choice for everyone, I always like to have a few alternatives that are either low in caffeine or caffeine-free to encourage hydration. I have many clients who drink coffee all day long, so I have a couple of tricks to help them stay hydrated without completely giving up their caffeine or adding a lot of sugar. Green tea: Green tea has less than half the caffeine that coffee does and significantly more antioxidants, most in the form of epigallocatechin gallate that has been shown to promote weight loss and improve glucose metabolism. Hibiscus tea: Hibiscus tea is caffeine free and may help to improve mild hypertension. Caffeinated sparkling water: Many brands have less caffeine per serving than a cup of coffee and can also be a great substitute for chronic soda drinkers. Iced coffee with a protein shake: This may be especially helpful for those who are in the habit of drinking several cups of coffee a day. Mix 8 ounces of cold brewed coffee with a 12-ounce protein shake for less caffeine over several hours to stay focused while decreasing the unpleasant side effects of caffeine intake. Ultimately, I want my clients to drink water for hydration in the warm summer months. But, if a fun and refreshing coffee drink like cloud coffee has them excited and offers a few health benefits as well, I'm on board.
Hamilton Spectator
4 days ago
- Hamilton Spectator
Drug User Advocacy Groups Challenge ‘Recriminalization' in Court
The federal government was in court this week listening to arguments that it made a mistake when it allowed British Columbia to roll back its decriminalization pilot project. Counsel for a coalition of 13 drug user advocacy groups argued in an application for a judicial review that Health Canada didn't properly consider all the evidence before it when it broadly recriminalized public drug use in 2024. Canadian drug laws are set out in the federal Controlled Drugs and Substances Act. To provincially change drug laws for decriminalization, B.C. had to ask Health Canada for an exemption under the act. It later asked Health Canada to amend that exemption to recriminalize public drug use. The process will see a federal judge examine the evidence that was available to the federal government at the time, and rule on whether or not the government's decision to allow the decriminalization rollback was fair. Justice Meaghan M. Conroy heard the coalition's arguments Monday and Health Canada's defence Tuesday. She is expected to make a decision in the coming months. She could agree the decision was unfair and ask Health Canada to go over the evidence again, say the decision was fair and no further action is needed, or something in between. While B.C.'s government has made a lot of changes since decriminalization was introduced in January 2023, the judicial review is looking at only the most recent change, which essentially made it illegal again to have or use drugs in all public spaces across B.C. Decriminalization was a three-year pilot project introduced by the BC NDP to help people access harm reduction services and reduce the number of fatal overdoses. It let anyone 18 and older carry and use up to 2.5 grams of opioids, methamphetamines, powdered cocaine or MDMA in most places across B.C. without risking arrest. There were some exemptions — drugs were not allowed on school grounds or licensed child-care facilities, for example. In September 2023 the province added to that list, making playgrounds, splash pads, wading pools and skate parks drug-free zones. One month later it attempted to amend decriminalization further with Bill 34, which would have given police additional powers to control people who use drugs, or people who were suspected of using drugs, and introduced a confusing patchwork of places where people weren't allowed to use drugs. But Bill 34 was blocked by a temporary injunction before it could come into force, after a judge said the bill could cause 'irreparable harms' to people who use drugs. After Bill 34 was blocked, the province asked Health Canada to make possession and public drug use illegal again in April 2024. Drugs were still allowed in homes or shelters. This has been dubbed 'recriminalization' by drug user advocacy groups. The request was approved by Health Canada. This decision is the subject of the judicial review. B.C.'s Ministry of Health told The Tyee that decriminalization is just one part of a multi-pronged approach it is taking to address toxic drug deaths. Drug deaths have been climbing since early 2014 when the synthetic opioid fentanyl started being added to illicit, unregulated drugs in the province. Unregulated drugs have killed more than 17,800 British Columbians since then. Representing the coalition were lawyers Lindsay Frame and Jack Ruttle, who argued recriminalization contravened the general goal of Canada's drug policies, which is to keep people healthy and safe. Prohibiting public drug use, Frame argued, will push people to use drugs while isolated or alone, which increases their risk of fatal overdose because someone might not be around to call 911, administer naloxone or provide first aid. The current unregulated drug supply is often referred to as 'toxic' because of the unpredictability and potency of the supply, which can mean a regular dose can include unexpected drugs, such as benzodiazepines, and be hundreds or thousands times more potent than expected. Representing the federal government was lawyer Adrienne Copithorne, who delivered a technical argument, focusing on how most of the coalition's complaints went against the broad drug prohibitions laid out in the Controlled Drugs and Substances Act, rather than Health Canada's decision to roll back decriminalization. Decriminalization didn't set a permanent standard that potential future harms can be compared against, she added. It was meant to be only a temporary measure that the health minister could adjust as needed. The federal government was asking to throw the case out due to these technicalities. How prohibition harms the most marginalized The court heard from the coalition that one reason B.C. asked Health Canada to recriminalize drugs was that police weren't able to maintain public order, and the 'vibrancy' of public spaces was being impacted by people who use drugs. But even with decriminalization, police still had laws against public intoxication, littering and trespassing, Frame said. Copithorne disagreed, pointing out how police tried to use the tools they had and later asked for more power when those tools weren't working. Frame said the public and political pushback against decriminalization often conflated poverty and the rise of homelessness with decriminalization. There is no evidence that decriminalization increased drug use, she said. But there was an increase in homelessness that made more people visible while they used drugs, she said. Copithorne said the core problem was still that people were using drugs in public and causing a disturbance. Frame also told the court that recriminalization disproportionately impacts marginalized communities, effectively treating them as second-class citizens. For example, remote Indigenous communities are less likely to have access to harm reduction sites where they can use while supervised by someone who can step in if there's an emergency, such as an overdose prevention site or supervised consumption site, she said. Indigenous people are disproportionately harmed by unregulated drugs, and recriminalizing drugs will reintroduce a lot of those harms, Frame said. At the time of Health Canada's decision to recriminalize drugs, the crisis was killing seven people in B.C. per day. Indigenous people were dying at six times the rate non-Indigenous people were, and First Nations women were dying at 12 times the rate of non-Indigenous women in the province, she said. 'Racism, colonialism and intergenerational trauma all contribute to these drug deaths,' Frame said. Copithorne said the change doesn't specifically target any particular groups and is applied to all people in B.C. equally. Frame argued that there is a 'profound unmet need for places to safely use' across the province, which means unhoused people have nowhere else to use but in public spaces. But using in public spaces increases a person's risk of interacting with a police officer, which can lead to arrest or drugs being confiscated. Both things increase a person's risk of a fatal overdose, Frame said. When someone's drugs are confiscated, Frame said, they might have to turn to an unfamiliar supply, risk going into life-threatening withdrawal or lose drug tolerance, which puts them at a higher risk of overdose the next time they use. An arrest can impact a person's housing, job or access to their children. 'Criminalization feeds into cycles of harm,' Frame said. Kali Rufus-Sedgemore said they feel 'hopeful' that Conroy 'will see the government did something wrong.' Rufus-Sedgemore is the executive director of the Coalition of Peers Dismantling the Drug War. They spoke to The Tyee on behalf of the coalition of 13 organizations that applied for the judicial review. Rufus-Sedgemore said politicians have been feeding into a 'mass hysteria' about people who use drugs, which ignores people's humanity and overlooks the reasons why they might take drugs. Rufus-Sedgemore, who has ADHD, takes methamphetamine, for example. They say drug use calms their brain down and lets them work effectively in their community. They sometimes use a prescription to treat their ADHD but say the medications are expensive, can make them sick and are not strong enough to properly medicate them. But police and health-care workers don't see that and treat Rufus-Sedgemore, who is from the 'Namgis First Nation/Kwakwaka'wakw, like they might become violent at any moment. This is something Indigenous people and stimulant users often have to deal with, Rufus-Sedgemore told The Tyee. 'I've never been violent,' they say softly. 'But if I go to St. Paul's [Hospital] I have to take a sobriety and drug test, with a security guard posted outside of my room. I don't drink and I have to wait for hours before someone even asks me what's wrong.' To actually end the ongoing toxic drug crisis, Rufus-Sedgemore said, the government needs to bring back decriminalization, introduce a regulated safer supply that is more accessible and actually separates people from the unregulated supply, and create comprehensive drug education for kids. They've worked with youth before and remember being asked if you can un-burn microwave popcorn by microwaving it again, or, if drugs are making you feel weird, taking more drugs will make you feel better. Kids are still figuring this world out and won't know something if we don't teach them, they said. Error! Sorry, there was an error processing your request. There was a problem with the recaptcha. Please try again. You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy . This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply. Want more of the latest from us? Sign up for more at our newsletter page .
